TY  - JOUR
AU  - Berciano-Guerrero, Miguel-Angel
AU  - Lavado-Valenzuela, Rocio
AU  - Moya, Aurelio
AU  - de-la-Cruz-Merino, Luis
AU  - Toscano, Fatima
AU  - Valdivia, Javier
AU  - Castellon, Victoria
AU  - Henao-Carrasco, Fernando
AU  - Sancho, Pilar
AU  - Onieva-Zafra, Juan-Luis
AU  - Navas-Delgado, Ismael
AU  - Rueda-Dominguez, Antonio
AU  - Perez-Ruiz, Elisabeth
AU  - Alba, Emilio
PY  - 2022
DO  - 10.3390/biomedicines10020284
SN  - 2227-9059
UR  - http://hdl.handle.net/10668/20815
T2  - Biomedicines
AB  - Targeted therapy in metastatic melanoma often achieves a major tumour regression response and significant long-term survival via the release of antigens that reinduce immunocompetence. The biomarkers thus activated may guide the prediction of...
LA  - en
PB  - MDPI
KW  - Biomarker
KW  - Immunology
KW  - Melanoma
KW  - Targeted therapy
KW  - Melanoma
KW  - Complement C1 Inhibitor Protein
KW  - Neoplasms, Second Primary
KW  - Immunocompetence
KW  - Gene Expression Profiling
TI  - Genes Involved in Immune Reinduction May Constitute Biomarkers of Response for Metastatic Melanoma Patients Treated with Targeted Therapy.
TY  - research article
VL  - 10
ER  -